Michel P Hermans et al.
European journal of clinical investigation, 42(7), 729-737 (2012-01-10)
Imbalance in nitric oxide (NO), an atheroprotective vasodilator, is associated with endothelial dysfunction, cardiovascular diseases (CVD) and diabetic complications. Various endothelial NO synthase (eNOS) polymorphisms may affect NO bioavailability, thereby promoting adverse cardiovascular milieu. To analyze glucose homeostasis, cardiometabolic phenotype